Elevation Wealth Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.6K Buy
67
+2
+3% +$778 0.01% 600
2026
Q2
$25.8K Buy
65
+7
+12% +$1.99K 0.01% 502
2026
Q1
$10.1K Buy
58
+35
+152% +$7.17K ﹤0.01% 511
2025
Q4
$5.89K Buy
23
+10
+77% +$2.62K ﹤0.01% 595
2025
Q3
$3.38K Buy
+13
New +$3.42K ﹤0.01% 543
2024
Q2
– Sell
-39
Closed -$13.5K – 525
2024
Q1
$13.5K Buy
+39
New +$14.8K 0.01% 331

Other funds holding HUM

Elevation Wealth Partners's HUM Position: Q3 2026 in Review

Elevation Wealth Partners increased its Humana (HUM) stake by 3.1% in Q3 2026, buying an estimated $778 and bringing the position to 67 shares worth $25.6K. The position accounts for 0.01% of the portfolio, ranked #600.

Elevation Wealth Partners first reported a position in HUM in Q1 2024 and has held it in 6 quarters since. The position peaked at $25.8K in Q2 2026. 37 funds tracked by Wall St. Rank hold HUM as of Q3 2026.

  • Elevation Wealth Partners held 67 shares of Humana worth $25.6K as of Q3 2026.
  • Elevation Wealth Partners bought 2 Humana shares in Q3 2026, an estimated $778.
  • Humana made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #600 holding.
  • Elevation Wealth Partners first reported a position in Humana in Q1 2024 and has held it in 6 quarters since.
  • Elevation Wealth Partners's Humana position peaked at $25.8K in Q2 2026.
  • 37 funds tracked by Wall St. Rank held Humana as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.